CD81 and Alzheimer disease: NDE Aβ42 values were consistently elevated in mild-to-moderate (p < 0.05; CD81-adjusted levels: 18.05 pg/ml) and in advanced AD stages (p < 0.05; CD81-adjusted levels: 23.06 pg/ml) but showed no differences between AD subgroups (Fig. 1a).